Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response

Amyloid. 2017 Mar;24(sup1):54-55. doi: 10.1080/13506129.2017.1289916.

Authors

Giovanni Palladini^{1

2}, Paolo Milani^{1

2}, Marco Basset^{1

2}, Francesca Russo^{1

2}, Francesca Lavatelli^{1

2}, Mario Nuvolone^{1

2}, Giovanni Ferraro^{1

2}, Margherita Bozzola^{1

2}, Andrea Foli^{1

2}, Stefano Perlini^{1

2}, Giampaolo Merlini^{1

2}

Affiliations

¹ a Amyloidosis Research and Treatment Center, Foundation (IRCCS) Policlinico San Matteo , Pavia , Italy and.
² b Department of Molecular Medicine , University of Pavia , Pavia , Italy.

PMID: 28434293
DOI: 10.1080/13506129.2017.1289916

No abstract available

Publication types

Letter

MeSH terms

Combined Modality Therapy
Heart Diseases / blood
Heart Diseases / etiology
Heart Diseases / mortality*
Heart Diseases / therapy
Humans
Immunoglobulin Light Chains / blood*
Immunoglobulin Light-chain Amyloidosis / blood
Immunoglobulin Light-chain Amyloidosis / complications
Immunoglobulin Light-chain Amyloidosis / mortality*
Immunoglobulin Light-chain Amyloidosis / therapy
Prognosis
Prospective Studies
Severity of Illness Index
Survival Rate

Substances

Immunoglobulin Light Chains